COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2167: Articles 21661-21670  | Next

Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
Padmanabhan, U., Mukherjee, S., Borse, R., Joshi, S., Deshmukh, R.
10.1101/2020.10.28.20221630 — Posted: 2020-11-03 Discussion: Onsite | Offsite
A chest-CT and clinical chemistry based flowchart for rapid COVID-19 triage at emergency departments - a multicenter study
Kurstjens, S., Göttgens, E.-L., Smit, B., Postma, B., Kluge, C., van der Horst, A., Lamboo, E. H. J., Janssen - Te Slaa, C. M. M., Herpers, R., Kluiters-de Hingh, Y. C. M., du Mee, A., Veuger, M., van Marum, R., de Jager, P., Elisen, M. G. L. M., Kusters, R., Schuijt, M., Thelen, M. H. M.
10.1101/2020.10.29.20218743 — Posted: 2020-11-03
ROLE OF CYTOKINES AND OTHER PROPHETIC VARIABLES IN THE DEVELOPMENT AND PROGRESSION OF DISEASE IN PATIENTS SUFFERING FROM COVID-19
malik, a., Iqbal, S., Waquar, S., Hafeez, M. M.
10.1101/2020.10.28.20221408 — Posted: 2020-11-03
Simple discrete-time self-exciting models can describe complex dynamic processes: a case study of COVID-19
Browning, R., Sulem, D., Mengersen, K., Rivoirard, V., Rousseau, J.
10.1101/2020.10.28.20221077 — Posted: 2020-11-03
The power and limitations of genomics to track COVID-19 outbreaks: a case study from New Zealand
Geoghegan, J. L., Douglas, J., Ren, X., Storey, M., Hadfield, J., Silander, O. K., Freed, N. E., Jelley, L., Jefferies, S., Sherwood, J., Paine, S., Huang, S., Sporle, A., Baker, M. G., Murdoch, D. R., Drummond, A. J., Welch, D., Simpson, C. R., French, N., Holmes, E. C., de Ligt, J.
10.1101/2020.10.28.20221853 — Posted: 2020-11-03
Residual SARS-CoV-2 viral antigens detected in gastrointestinal and hepatic tissues from two recovered COVID-19 patients
Cheung, C. C. L., Goh, D., Lim, X., Tien, T. Z., Lim, J. C. T., Nerurkar, S. N., Loong, S., Cheow, P. C., Chan, C. Y., Koh, Y. X., Tan, T. T., Kalimuddin, S., Tai, W. M. D., Ng, J. L., Low, J. G. H., Yeong, J., Lim, T. K. H.
10.1101/2020.10.28.20219014 — Posted: 2020-11-03
Sample pooling, a population screening strategy for SARS-CoV2 to prevent future outbreak and mitigate the second-wave of infection of the virus
Sawarkar, S. S., Victor, A., Viotti, M., Haran, S. P., Verma, S., Griffin, D., Sams, J.
10.1101/2020.10.29.20204974 — Posted: 2020-11-03
Public Mobility Data Enables COVID-19 Forecasting and Management at Local and Global Scales
Ilin, C., Annan-Phan, S., Tai, X. H., Mehra, S., Hsiang, S. M., Blumenstock, J. E.
10.1101/2020.10.29.20222547 — Posted: 2020-11-03
The Role of Societal Aspects in the Formation of Official COVID-19 Reports: A Data-Driven Analysis
Kurbucz, M. T., Katona, A. I., Lantos, Z., Kosztyan, Z. T.
10.1101/2020.10.28.20221572 — Posted: 2020-11-03
Causal Impacts of Teaching Modality on U.S. COVID-19 Spread in Fall 2020 Semester
Badruddoza, S., Amin, M. D.
10.1101/2020.10.28.20221986 — Posted: 2020-11-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).